Wontech, a leader in laser and energy-based medical solutions, announced on Friday that it secured new contracts across four global regions during the IMCAS World Congress 2026 held last month in Paris, France.
IMCAS, a prestigious international academic event, brings together cosmetic and dermatological experts worldwide to exchange cutting-edge clinical trends and treatment techniques.
At the exhibition, Wontech showcased its technological prowess by featuring flagship products such as Oligio X, Lavieen, and TIGHTAN, complemented by live demonstration sessions.
During the congress, Wontech hosted an exclusive Master’s Class in Paris at the Peninsula Hotel, offering a platform to share clinical data-driven treatment experiences and market implementation strategies.
Wontech successfully inked new supply agreements with eight countries across four key regions at IMCAS: Europe (Poland and Russia), the Middle East (United Arab Emirates and Saudi Arabia), Southeast Asia (Indonesia, Singapore, and Malaysia), and Latin America (Mexico).
Ongoing discussions for additional partnerships suggest further expansion of Wontech’s global footprint in terms of contracted countries and regions.
The simultaneous signing of contracts across four regions at a single event underscores the growing global recognition of Wontech’s product excellence and clinical reliability.
A spokesperson for Wontech emphasized that this IMCAS served as more than just a product showcase. It provided a valuable opportunity to validate the clinical data directly with international medical professionals and gather real-world insights. It plans to capitalize on this success to accelerate ongoing negotiations and further solidify Wontech’s position in the global aesthetic medical device market.